Shingles: Symptoms and Treatment — Why Timing Matters

Shingles (herpes zoster) is caused by the varicella-zoster virus (VZV) — exactly the same virus that caused chickenpox in the vast majority of us in childhood. After chickenpox resolves, the virus doesn't disappear from the body: it remains dormant in nerve ganglia, most often near the spinal cord, where it can persist for decades without causing any symptoms. Shingles appears when this dormant virus reactivates and travels along a sensory nerve to the skin, causing a characteristic, painful, blistering rash usually confined to one side of the body, within a single dermatome (an area of skin innervated by a single spinal nerve).

The key factor enabling this reactivation is a weakening of VZV-specific cellular immunity — most often related to the natural aging of the immune system (immunosenescence), but also to conditions that suppress immunity, immunosuppressive treatment, severe physical or psychological stress, or chronic systemic diseases. This is why the risk of shingles rises clearly with age — even though the virus has been "waiting" in the body since childhood, in most people it doesn't manifest until middle or older age, when the immune system loses some of its ability to keep it dormant.

The typical course begins with a prodromal phase, usually lasting 1-5 days, in which pain, burning, tingling, or skin hypersensitivity appears within a single dermatome, before any visible rash develops. This early pain is sometimes mistakenly attributed to other causes — muscle pain, intercostal neuralgia, or, in some locations, even cardiac problems — which can delay diagnosis until the characteristic rash appears.

This is exactly why clinical guidelines consistently recommend starting antiviral treatment (acyclovir, valacyclovir, or famciclovir) ideally within 72 hours of the rash appearing — after that window, viral replication has largely subsided naturally, and the benefit from antivirals is much smaller, though treatment may still be considered in severe cases, complications, or in immunocompromised patients even beyond that deadline.

Postherpetic neuralgia (PHN) is chronic pain persisting in the area of the former rash after the skin lesions have healed, usually defined as pain lasting longer than 90 days from the onset of illness. It's the most common complication of shingles, affecting roughly one in five people who've had it — with risk rising clearly with the patient's age at the time of illness.

This result doesn't mean antiviral treatment is pointless — it still shortens the acute phase of illness and speeds healing, and as the famciclovir trial showed, it also shortens the duration of pain in those who do develop PHN. It simply means antiviral therapy alone isn't a sufficient strategy for preventing this specific complication — hence the growing importance of preventive vaccination, described further below.

Shingles is often dismissed as "just a rash" — until someone experiences postherpetic neuralgia, a pain that can persist for months and significantly worsen quality of life, especially in older patients. Two things matter most here, and are well documented: how quickly you react to the first symptoms (that first 72-hour window) and, for people of the appropriate age, the decision to get vaccinated preventively before reactivation even happens.

If you suspect you have shingles — especially one-sided pain preceding a rash within a single band of skin — don't wait for "certainty" about the diagnosis: contact a doctor as soon as possible, since it's precisely the time from symptom onset to starting treatment that has the greatest documented impact on the course of the illness.